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Abstract
Plant derived phenolic compounds have been shown to inhibit the initiation and progression of cancers by
modulating genes regulating key processes such as: (a) oncogenic transformation of normal cells; (b) growth and
development of tumors; and (c) angiogenesis and metastasis. Recent studies focusing on identifying the molecular
basis of plant phenolics-induced cancer cell death have demonstrated down-regulation of: (a) oncogenic survival
kinases such as PI3K and Akt; (b) cell proliferation regulators that include Erk1/2, D-type Cyclins, and Cyclin
Dependent Kinases (CDKs); (c) transcription factors such as NF-kβ, NRF2 and STATs; (d) histone deacetylases HDAC1
and HDAC2; and (e) angiogenic factors VEGF, FGFR1 and MIC-1. Furthermore, while inhibiting oncogenic proteins,
the phenolic compounds elevate the expression of tumor suppressor proteins p53, PTEN, p21, and p27. In addition,
plant phenolic compounds and the herbal extracts rich in phenolic compounds modulate the levels of reactive
oxygen species (ROS) in cells thereby regulate cell proliferation, survival and apoptosis. Furthermore, recent studies
have demonstrated that phenolic compounds undergo transformation in gut microbiota thereby acquire additional
properties that promote their biological activities. In vitro observations, preclinical and epidemiological studies have
shown the involvement of plant phenolic acids in retarding the cancer growth. However, to date, there is no
clinical trial as such testing the role of plant phenolic compounds for inhibiting tumor growth in humans. More
over, several variations in response to phenolic acid rich diets-mediated treatment among individuals have also
been reported, raising concerns about whether phenolic acids could be used for treating cancers. Therefore, we
have made an attempt to (a) address the key structural features of phenolic acids required for exhibiting potent
anti-cancer activity; (b) review the reported findings about the mechanisms of action of phenolic compounds and
their transformation by gut microbiota; and (c) update the toxicological aspects and anti-tumor properties of
phenolic compounds and extracts containing phenolic compounds in animals.
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Introduction
Phenolic compounds are secondary metabolites in plants
with a common aromatic ring bearing one or more hy-
droxyl groups [1]. More than 8000 natural phenolic
compounds have been identified to date [2]. Phenolic
compounds isolated from plant sources include simple
phenols, flavonoids, lignins and lignans, tannins, xan-
thones, and coumarins [3]. These phenolic compounds
are known to exhibit potent anti-cancer activities as well
as combat various diseases associated with oxidative
stress [4]. Prior studies have demonstrated that the
health beneficial effects of dietary phenols are due to
their ability to exhibit antioxidant, anti-inflammatory
and anti-clastogenic activities [5]. Anti-carcinogenic ef-
fects of phenolic compounds is primarily due to the abil-
ity to: (a) induce cell cycle arrest; (b) inhibit oncogenic
signaling cascades controlling cell proliferation, angio-
genesis and apoptosis; (c) modulate ROS levels; (d) pro-
mote tumor suppressor proteins such as p53; and (e)
enhance the ability to differentiate and transform in to
normal cells etc. In this review article, we have discussed
the anti-carcinogenic effects of simple phenolic com-
pounds while addressing the mechanistic basis of tumor
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inhibition and various toxicological issues associated
with the use of phenolic compounds.
Classification of plant phenolics
Phenylalanine and/or tyrosine are the precursors for the
synthesis of phenolic acids through shikimate pathway
[6] (Fig. 1). Addition of hydroxyl groups into the phenyl
ring is the key step involved in the biosynthesis of phen-
olic acids [6]. Due to the heterogeneous structures of
these phenolic acids, which range from low molecular
weight single aromatic ring structure to high molecular
weight polymeric compounds, they can be broadly clas-
sified into simple and complex phenolics (Fig. 2), which
are discussed in detail in the following sections.
Simple Phenolics
Benzoic acids (BA) and cinnamic acids (CA) are the
most simple phenolic acids found in nature with 6- and
9- carbon skeletons [7]. These compounds contain a car-
boxylic group attached to the benzene ring with one or
more hydroxyl or methoxyl groups attached to it [8]. For
example, gallic acid has three hydroxy (-OH) groups at-
tached at 3rd (meta), 4th (para) and 5th (meta) carbon,
whereas the syringic acid contain two methoxy (-OCH3)
groups at 3rd and 5th (meta) and one -OH group at 4th
carbon (para) [9]. The cinnamic acids in addition, have a
unsaturated propionic acid side chain attached to the
benzene ring [10]. Caffeic acid contains two -OH groups
at 3rd and 4th carbon while Ferulic acid has one -OCH3
and one -OH group attached at 3rd and 4th carbon
atoms respectively. Structures of benzoic and cinnamic
acid derived phenolic compounds that are most com-
monly found in plants are shown in Table 1.
Complex Phenolics
Complex phenolics are compounds with higher molecular
weight. These phenolic acids are most commonly found in
cell vacuoles [11]. Tannins and flavonoids are the best ex-
amples for complex phenolics found among fruits and
vegetables [12]. Flavonoids are made up of 2 phenolic
rings to which an oxygenated heterocyclic pyran ring is at-
tached [13]. The oxygenated status of the pyran ring fur-
ther classifies flavonoids into: anthocyanins, flavones,
flavanols etc. Higher complexity is achieved due to the
acetylation or glycosylation of these molecules beyond
their primary substitutions with hydroxyl or methoxyl
groups [14]. Since the focus of this review article is on
simple phenolic compounds the details pertaining to com-
plex phenolic compounds is not much discussed. For de-
tailed structural and functional aspects of flavonoids and
their derivatives the reader can refer recent review articles
as shown in references [2, 13, 15].
Distribution of phenolics in various parts of the plants
Phenolic acids are widely distributed among various parts
of the plants including roots, leaves, fruits and vegetables
[16]. The caffeic acid is the most common type of phen-
olic acid found widely in the fruits, while the ferulic acid is
Fig. 1 Synthesis of plant phenolic compounds by shikimate pathway, shows the biosynthetic pathway of plant phenolic acids [135]. The
phosphoenolpyruvate react with erythrose-4-phosphate to give chorismic acid, which is a precursor for tyrosine and phenylalanine which later
serves as precursors for cinnamic acid derivatives. Predominantly benzoic acids are synthesized from chorismic acid via oxidative and non-
oxidative pathways while iso chorismic acid serve as precursor for protocatechuic acid [136]
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found in the cell walls of seed coat, bran and fruits in es-
terified form [17]. The leaves and stems of plants contain
higher levels of phenolic acids with significant variations
found among different species [16]. For instance, complex
polyphenols are found in the cell vacuoles, tissues present
in the leaf, epidermis, flowers and fruits [12]. Likewise,
barks, wood and fruit pods are rich in tannins, while
flowers contain more flavonoids [18].
Dietary sources
Plant phenolic acids form an integral part of our diet and
thus making them a prime focus of interest. For example,
cereals, legumes, soybeans, coffee, tea, rosemary and
thyme, which are widely utilized in diet, are the rich
sources of phenolic acids [19]. A study has shown that
gallic acid is the most common phenolic acid found
among fruits, vegetables, chestnuts and green chicory
[20]. While a separate study by Kivilompolo M 2007 et al.,
reported that herbs like thyme, oregano and sage are rich
in caffeic acids [21], another study by J Perez-Jimenez
2010 et al., identified polyphenolic compounds in the sea-
sonings such as star anise, cloves, peppermint and celery
seeds [22]. Fruits from berry and citrus family members,
apples and pears have also known to contain considerable
amounts of phenolic acids [12]. Among vegetables the yel-
low onions followed by artichokes, potatoes, rhubarb, red
cabbage and cherry tomatoes harbor high phenolic con-
tent [23, 24]. Among the different vegetables consumed,
the potatoes account for up to 25% of total phenolics such
as chlorogenic acid and caffeic acid [25].
Nutritive value
Phenolic acids are the major essential non-nutrients
present in the diet. However, most often, they are con-
sidered as antinutrients due to the adverse effects of
tannins on protein digestibility [26]. But, in recent years,
an increased interest in developing diets rich in plant de-
rived polyphenols is observed due to the realization that
the phenolic compounds exhibit anti-oxidant, anti-
inflammatory and anti-proliferative effects [4]. Since
these activities are essential for preventing or treating
cancers, cardiovascular diseases, atherosclerosis and
neurodegenerative disorders, supplementing diets with
extracts rich phenolic compounds help to effectively
manage these disorders [27]. For instance, polyphenols
from green tea were shown to inhibit the progression of
tumors in different animal models [28]. Similarly, a
much lowered risk of colon, prostate and breast cancers
observed among the Asian population was attributed to
the intake of polyphenol and flavonoid rich diets [29]. In
addition, a study carried out in Finland reported health-
ier carotid arteries with less obstruction from athero-
sclerosis when individuals consumed higher amounts of
flavonoids and polyphenols [30]. Likewise, a separate
study in France revealed that individuals consuming di-
ets supplemented with flavonoid-based plant products
had lesser incidence of cognitive disorders over the age
of 65 years [31]. In summary, these studies highlight the
importance of consuming diets with phenolic com-
pounds in mitigating the disease severity.
Metabolism of phenolic compounds by gut microbiota
The polyphenolic compounds present in nature are usu-
ally glycosylated and exist as complex molecules with poor
solubility and less bioavailability [32]. Once ingested in
diet, these complex insoluble phenolics undergo trans-
formation in the human gastro-intestinal tract by the en-
zymes and microbiota to produce phenolic compounds
with more bioavailability and better pharmacological
properties [32]. For example, a recent study has demon-
strated that ellagic acid, a phenolic acid derived from ber-
ries, is transformed by the gut microbiota in to urolithin.
The bio-transformed urolithin effectively inhibits heme
peroxidases such as myeloperoxidase and lactoperoxidase
thereby reduce the inflammation mediated cellular dam-
age [33]. In addition, urolithin reduces superoxide radicals’
generation while ellagic acid failed to do so [33]. In animal
models oral administration of urolithin, at 40 mg/kg body
weight, inhibited PMA-induced edema and MPO activity
compared to ellagic acid [33]. A separate study by Marin
et al., demonstrated the production of soluble phenolic
compounds such as ferulic acid and coumaric acid by the
hydrolytic activity of gut microbiota on ester linked arabi-
noxylans [32]. Additional studies have further shown that
the dimers of ferulic acid are degraded by micro-
organisms present in the gut in to vanillin and 3-(4-hydro-
xyphenyl)-propionic acid with enhanced anti-cancer
activity [32]. Therefore, transformation of phenolic com-
pounds by gut microbiota has several important roles and
Fig. 2 Classifications of the plant phenols, based on their structure.
Broadly plant phenolic compounds are classified as simple and
complex phenolic acids. Simple phenolic acids are further classified
as benzoic and cinnamic acid derivatives while complex phenolic
acids are classified as flavonoids, tannins and stilbenes
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Table 1 Structures of benzoic and cinnamic acid derivatives commonly found in plants
Common name Structure IUPAC name Molar Mass
in g/mol
Primary source Ref






Cinnamylic acid 3-phenylprop-2-enoic acid 148.16 Cinnamon oil [137]
p-Hydroxybenzoic
acid
















Gallic acid 3,4,5,Trihydroxy Benzoic acid 170.12 Chestnut Green
chicory
[20]
Vanillic acid 4-Hydroxy-3-methoxybenzoic acid 168.14 Vinegar Wine [140]
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influences their biochemical properties as well as contrib-
ute for the variations in the response to treatment with
phenolic compounds among individual [34] (Fig. 3).
Anticancer activities of crude extracts/mixture of phenolic
compounds
Purification of phenolic compounds from natural sources
to homogeneity is a challenging task. Therefore, several
studies have tested the ability of either crude extracts rich
in phenolic compounds or the fractions containing a
mixture of phenolic compounds for inhibiting cancers in
vitro and in vivo. For example the extracts of Pandanus
amaryllifolius (herbal plant from Malaysian region) con-
taining gallic acid, cinnamic acid and ferulic acid are re-
ported to inhibit breast cancer cell lines in vitro [35].
Similarly, the extracts of Baccharis trimera, containing
gallic acid, pyrogallol, syringic acid and caffeic acid were
shown to suppress the formation of tumor cell colonies
and proliferation of SiHa cells in a dose dependent manner
[36]. Likewise, Thanaset et al., 2014 have demonstrated the



























Table 1 shows the structures, common and IUPAC names along with the molecular mass of commonly found BA and CA derivatives. References that have
discussed about these phenolic compounds are also listed
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time- and dose dependent growth inhibitory effect of water
soluble constituents of commercially available Houttuynia
cordata fermentation products on HeLa, HCT116, and
HT29 cells. Seven phenolic acids including protocatechuic,
p-hydroxybenzoic, vanillic, syringic, p-coumaric, ferulic,
and sinapic acids were identified in the water soluble frac-
tion of H.cordata [37]. Another study isolated and charac-
terized gallic acid from Toona sinensis leaf extracts which
inhibited the growth of prostate cancer cell lines [38]. In a
separate study Kurata et al 2007, could identify caffeic acid,
chlorogenic acid, 3,4-di-O-caffeoylquinic acid, 3,5-di-O-
caffeoylquinic acid, 4,5-di-O-caffeoylquinic acid, and 3,4,5-
tri-O-caffeoylquinic acid in the leaves of the sweet potatoes
inhibited the growth of stomach cancer (Kato III), a colon
cancer (DLD-1), and a promyelocytic leukemia cell (HL-
60) [39]. Thus it can be concluded that the antitumor ac-
tivity exerted by these plant extracts could be due to the
presence of phenolic acids. However, utility of crude ex-
tracts containing a mixture of phenolic compounds as
drugs require more careful investigations as the proportion
of each phenolic compound in the extract might vary from
source to source as well as from the method of isolation
and fractionation.
Key structural features and mechanism of action
of plant phenolics
Even though phenolic compounds have been shown to
exhibit anticancer activity, the efficacy varies from one
compound to other, which is due to the variations in
their structures as well as their molecular targets. For
example, structure activity relationship studies delineat-
ing the key functional groups required for exhibiting po-
tent anti-cancer effects of phenolic compounds have
identified the involvement of aromatic ring and hydrox-
ylic groups [40, 41], (Fig. 4). Compounds with more
number of hydroxylic groups exhibited better anticancer
activity compared to the ones with no hydroxylic groups
or compounds with –OCH3 moieties. For instance,
gallic acid that contains three hydroxylic groups is re-
ported to be more effective compared to dihydroxy ben-
zoic acid or monohydroxy benzoic acid. In addition to
hydroxylic groups and catechol ring structure, the pres-
ence of an unsaturated short fatty acid side chain also
makes the phenolic compounds more potent. As an ex-
ample, studies comparing the efficacy of cinnamic acid
and benzoic acid for inhibiting cancer cell growth re-
vealed that cinnamic acids that contain a unsaturated
propionic acid side chain are more better anti-cancer
agents [40, 41]. Thus phenolic acids i.e benzoic and cin-
namic acid derivatives with higher hydroxyl substitutions
could be considered as potential candidates for prevent-
ing the cancer cell proliferation.
Benzoic acid derivatives such as gallic acid, protocate-
chuic acids that are commonly found in nature have
Fig. 4 Key structural motifs responsible for anticancer activity Studies
on the structure-activity-relationship (SAR) of phenolic compounds
have identified the aromatic ring (represented with an arrow), number
and position of free hydroxyl groups (represented with a circle) and
unsaturated fatty acid chain as key structural motifs required for
exhibiting anticancer activity (represented with square)
Fig. 3 Gut microbiota mediates the transformation of phenolic compounds and enhance the health beneficial effects. Bound and complex phenolic
compounds undergo bio-transformation in the human gastro intestinal tract by the gut microbiota into simple and easily bioavailable phenolic
compounds. The active metabolites produced by the biotransformation have proven to exhibit better pharmacological actions and possess better
health beneficial properties compared to corresponding untransformed compounds
Anantharaju et al. Nutrition Journal  (2016) 15:99 Page 6 of 16
attained much attention due to their better pharmaco-
logical properties [42–44]. For instance, hydroxybenzoic
acids and protocatechuic acid have been reported to ex-
hibit dose dependent cytotoxicity on prostate (PC-3) and
breast (MCF-7) cancer cells [45]. Mechanistically, 4-
hydroxy benzoic acid inhibited the histone deacetylase
enzyme thus modifying the acetylation process thereby
inducing the cancer cell death [46]. Protocatechuic acid
targets the RhoB activation leading to decreased MMP
thus inhibiting the cancer cell migration [44]. These
compounds induce apoptosis, and enhance lactate de-
hydrogenase levels by reducing the mitochondrial mem-
brane potential. In addition, these compounds trigger
the fragmentation of DNA in breast, lung, liver and
prostate cancer cell lines [47]. Similarly, gallic acid in-
hibits the cancer cell proliferation by promoting the gen-
eration of reactive oxygen species and arresting cells in
G2/M phase [38]. Cinnamic acid derivatives CAPE- caf-
feic acid phenyl ester and Caffeic acid are also well
known antioxidants, reported to modulate key signaling
pathways such as NF- kβ, MAPK and AKT [48]. Fur-
thermore, CAPE and CAA induced cell death via apop-
tosis and cell cycle arrest in cell lines representing
carcinomas of oral cavity, neck and tongue [40, 49, 50].
In addition, CAPE is known to inhibit the nuclear factor
kappa-light chain enhancer of activated B cells i.e NF-
kβ, which further enhanced the expression levels of p21,
p53 [51]. P-Coumaric acid, an abundant isomer of cin-
namic acid, inhibits the colon cancer cell lines by in-
creasing the ROS levels, decreasing the mitochondrial
membrane potential and inhibiting the cell cycle at sub
G1 phase [52]. Esters of cinnamic acids are more potent
when compared to the hydroxylated or the methoxylated
versions [40]. Among the 20 different caffeic acid ana-
logues, 4-phenylbutyl caffeate, (Z)-8-phenyl-7-octenyl
and (E)-8-phenyl-7-octenyl caffeate exhibited potent
anti-tumor activity with EC50value of 0.02 μM [53].
In vitro studies
Effect on cell viability and proliferation
Uncontrolled cellular proliferation is a hall mark feature
of cancer cells [54]. Therefore, the efficiency of anticancer
drugs can be measured by their ability to: (a) decrease cell
proliferation measured using the incorporation of tritiated
Thymidine or Bromodeoxy Uridine; (b) attenuate the via-
bility of cells as measured using MTT or SRB; (c) arrest
the cells in interphase (G0/G1, S or G2/M) [55]. Phenolic
compounds isolated from plant sources have been demon-
strated to inhibit the proliferation of cancer cells [12]. For
example, cinnamic acid reduced the viability of HT-44
melanoma cell line in a dose dependent manner with the
IC50 of 2.4 mM [56]. Mechanistically, cinnamic acid de-
creased the number of S phase cells thereby inhibited the
proliferation of HT-44 cells [56]. Likewise, a separate
study showed the induction of cell cycle arrest at G2/M
phase when breast cancer cells MDA-MB-231 and MCF-7
were exposed to 4-(3,4,5-Trimethoxyphenoxy) benzoic
acid [57]. Similarly, many other studies have also demon-
strated the efficacy of phenolic compounds to retard can-
cer cell proliferation [52]. For instance, p-coumaric acid
decreased the viability of HCT-15 and HT-29 cells at a
concentration of 1400 and 1600 μmol/L, respectively [52].
Reduction in the number of colonies formed in the cou-
maric acid treated HCT-15 (32) and HT-29 (51) against
the untreated (105 and 154) at 72 h confirmed the anti-
proliferative effects of these compounds [52]. Other phen-
olic acids that have shown to exhibit antiproliferative ac-
tivity include: (a) Caffeic- and 5-caffeoylquinic acid that
reduced the cell viability of HT-29 colorectal carcinoma
cell line and HT-1080 fibrosarcoma cells at 96 h by modu-
lating cell cycle stages [58, 59]; (b) Di-caffeoylquinic acid,
isolated from sweet potato, which inhibited the prolifera-
tion of DLD-1 human colon cancer cells [39]; (c) Ferulic
acid and p-Coumaric acid that were shown to inhibit the
pancreatic cancer cell line MIA-Pa-Ca-2 [60]; (d) Gallic
acid, which inhibited cervical carcinomas cells HeLa and
HTB-35 and Jukart [61, 62]. Similarly, even the phenyl
substituted cinnamic acids also exhibited significant cyto-
toxicity in HT-29, A-549, OAW-42, MDA-MB-231 and
HeLa cell lines with IC50 values of <60 μM [63]. Efficacy
evaluation studies comparing the potency of phenyl
substituted acids reported that at 0.1 mM concentration
~84–92% cells were killed compared to the non-
substituted derivatives, which had an effect of ~20–63%
[63]. The IC50 values of phenolic compounds are tabulated
in Table 2. In conclusion both cinnamic and benzoic acid
derivatives possess potent anti-proliferative activity as evi-
dent by the low IC50 values exhibited by them on several
cancer cell lines.
Effect on cellular apoptosis
Apoptosis, a suicidal cell death mechanism, is a well-
controlled process that gets activated either by the intrin-
sic or the extrinsic pathways [64]. The cells undergoing
apoptosis exhibit caspase mediated cell death through
transforming pro-caspases into active caspases [64].
Whereas the extrinsic pathway gets activated when the
binding of Fas ligands to Fas proteins, the intrinsic path-
way is triggered by oxidative stress inside the cells releas-
ing the cytochrome-C from the disrupted mitochondria
[65]. A prior study reported the induction of caspase-9
when HT-44 cells were treated with cinnamic acid [56].
Activated caspase-9 in turn activated other caspases such
as Caspase-3 and -7 [56]. A separate study demonstrated
that Ferulic acid could upregulate Bax and downregulate
Bcl-2 to induce apoptosis in osteosarcoma cells [64]. Simi-
larly, FA has induced the expression of Bax, caspase-3 and
-9 in fibrosarcoma cells [60]. Elevated caspase-3 was also
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observed when breast cancer cells were treated with 4-
(3,4,5-Trimethoxyphenoxy) benzoic acid [57]. Propidium
iodide staining of cells followed by analyzing the stained
cells with flow cytometer is another way of measuring the
apoptotic cell death [66]. Elevated subG0/G1 population
is a clear indicator of apoptosis induced by pharmaco-
logical agents promoting DNA damage [67]. A recent
study showed that colon cancer cells treated with p-
coumaric acid have undergone apoptosis as evidenced by
a significant increase in the subG1 phase cell population
[52]. Further confirming this data, analysis of cellular im-
ages captured by scanning electron microscope (SEM) ex-
hibited typical signs of apoptosis such as membrane
blebbing and shrinkage, which were absent among the
normal cells [52]. Likewise, Protocatechuic acid also ele-
vated the caspase-3 levels and reduced the membrane po-
tential in breast, prostate, lung, cervical and hepatic cell
lines in a dose dependent manner [47]. Similarly, a dose
dependent increase in the caffeic acid concentration re-
sulted in an increase in the apoptosis in human HT-1080
fibrosarcoma cell line [59]. Induction of apoptosis by caf-
feic acid was confirmed by the morphological changes and
the acridine orange and ethidium bromide staining
methods [59]. In summary, the induction of apoptosis is a
major phenomenon exhibited by phenolic compounds.
Effect on cellular migration
Tumor cell migration and invasions are the strategies
developed and adopted by cancer cells to localize into
distant organs and to escape drug treatment [68]. Since
metastatic tumor cells are hard to treat due to their
ability to circulate in the blood as well as unusual ex-
pression of oncogenic proteins compared to primary tu-
mors, better strategies are required to prevent the
metastatic spread [54]. One such strategy is to use natur-
ally occurring plant derived phenolic compounds, which
are known to halt the migration of cells by interfering
with epithelial-to-mesenchymal transition (EMT), cell
invasion and extravasation [69]. For instance, ferulic acid
suppressed metastasis in breast cancer cell lines by re-
versing the epithelial-mesenchymal transition (EMT)
[69]. Similarly, 4-methyl-3-nitrobenzoic acid derivative
inhibited the epidermal growth factor (EGF)-induced
migration and chemotaxis of breast cancer cell lines
[57]. Caffeic acid phenyl esters inhibited the metastasis
of breast (MDA-MB-231 and MDA-MB-468), colon
(SW620) and non-small cell lung cancer (H460) cell
lines by blocking the voltage-gated sodium channels
[70]. Recent studies have shown that voltage-gated so-
dium channels could modulate vascular endothelial
growth factor (VEGF)-induced proliferation, tubular dif-
ferentiation and adhesion by elevating the intracellular
Ca2+, which activates PKC and ERK-1/2 [71]. However,
in a separate study the caffeic acid phenyl esters was
shown to retard migration of cells by 38, 56, and 82% at
24, 48, and 72 h, respectively [72]. Gallic acid, another
simple phenolic compound, also increased the expres-
sion of RhoB thereby inhibiting the metastasis of gastric
cancer cells [43]. In summary these phenolic acids in-
hibit tumor cell migration and invasions and thus
localize the cancer cells thereby sensitizing them to
drugs.
Table 2 Reported anti-cancer activities of plant phenolic acids
Phenolic Acid/Phenolic Acid Derivative Cancers Tested Cell Lines Used Reported IC50
(μM)
Reference
Cinnamic acid Melanoma HT-144 2400.0 [56]
Colon HT-29 1000.0 [91]
Caffeic acid phenyl ester Prostate LNCaP 33.0 [145]
Breast MDA-MB-231 14.0 [146]
Hs578T 8.0
p-Coumaric acid Neuroblastoma N2a 104.0 [147]
Breast T47D 474.0 [148]
Colon SW-620 87.0 [148]
Liver HepG2 215.0 [148]
Lung A549 412.0 [148]
Ferulic acid Prostate PC-3 300.0 [149]
LNCaP 500.0
Pancreatic MIA PaCa-2 500.0 [60]
Gallic acid Colon HCT-15 0.5 [150]
Breast MDA-MB-231 0.4 [150]
Table 2 summarizes the anticancer activity of the plant phenolic acids on various cell lines with their IC50 values. The IC50 values varied from nM to
mM concentrations
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In vivo studies
Toxicity studies
Compared to many synthetic and semi-synthetic com-
pounds, naturally occurring phenolic compounds are
less toxic and safe even at higher doses [73]. However,
before evaluating in the clinical trials, one has to deter-
mine the safety and toxicity profiles of phenolic com-
pounds using animal models. Since some of the phenolic
compounds are also known to induce the formation of
tumors by transforming the normal cells, it is mandatory
to study the safety and toxicity of these plant derived
products [74]. Protocatechuic acid is another phenolic
compound tested in mice for safety and toxicity. The
LD50 of protocatechuic acid in mice was reported to be
800 mg/kg by i.p., and 3.5 g/kg by i.v. route [75]. How-
ever, when administered orally, the LD50 of protocate-
chuic aldehyde was about 1.7 g/kg [75]. Sub-chronic
toxicity assessment of gallic acid, a well-known antioxi-
dant benzoic acid derivative, in rats showed a relatively
safe profile [76]. Experimentally, rats fed with gallic acid
(0, 0.2, 0.6, 1.7 and 5%) containing diet for 13 weeks ex-
hibited no toxic symptoms even at 119 and 128 mg/kg/
day for male and female rats, respectively [76]. In mice,
oral administration of a dose up to 5000 mg/kg was also
found to be safe [77]. Compared to gallic acid, p-
coumaric acid exhibited low toxicity with LD50 ~
2850 mg/kg body weight [78]. In conclusion, the safety
and toxicity profiles of phenolic compounds vary de-
pending upon their structure, route of administration
and the animals that are being studied. Therefore, it is
recommended to determine the safety and toxicity pro-
files of phenolic compounds before moving them in to
preclinical and clinical studies.
Efficacy studies
Efficacy of a compound depends on its absorption, dis-
tribution, metabolism, excretion, availability, stability,
route of administration, target specificity and ability to
control key pathways regulating cancer cell proliferation
[79]. A number of studies have reported variability in
these properties for various plant phenolic compounds.
Most of the soluble phenolic acids are rapidly absorbed
in the small intestine while the insoluble esterified forms
are absorbed in the colon [80, 81]. The phenolic acids
are rapidly absorbed by the Monocarboxylic acid trans-
porters (MCT) or through para-cellular diffusion [82],
while, excretion is majorly through urine with only a low
percent of it is through bile [83].
Phenolic compounds with good ADME properties are
likely to exhibit potent anti-tumor activities [84]. For ex-
ample, caffeic acid phenyl propyl ester (CAPPE) and caf-
feic acid phenyl ethyl ester (CAPE), which are the better
bioavailable versions of caffeic acid, significantly inhib-
ited the growth of colorectal tumors in xenografted
mouse models by decreasing the number of proliferating
cells as evident by reduced expression of proliferating
cell nuclear antigen (PCNA), and by inhibiting fatty acid
synthetase (FASN) as well as matrix metalloproteinase 9
(MMP-9) [85]. Likewise, a separate study showed that
athymic mice harboring HepG2 xenografted tumors
were susceptible to growth inhibition when treated sub-
cutaneously (5 mg/kg, thrice a week up-to 10 days) or
orally (20 mg/kg, daily up-to 6 weeks) with CAA and
CAPE [86]. The data revealed that tumor size decreased
significantly as evident by 61 and 56.7% inhibition
among the CAA and CAPE subcutaneously treated
groups respectively [86]. However, when these com-
pounds were administered orally, the reduction was
around 53.6 and 47.1%, respectively with caffeic acid and
caffeic acid phenyl ester groups [86]. Similarly, 10 mg/kg
of CAPE administered intraperitoneally inhibited the de-
velopment of cholangiocarcinoma [87]. Anti-cancer ac-
tivity of other phenolic compounds is also well explored
[33, 80, 81]. For instance, a recent study has shown that
oral administration of protocatechuic acid at a dose of
20 and 40 mg/100 g reduced the metastatic nodule for-
mation in C57/BL6 mice [44]. In a similar fashion, feru-
lic acid at a dose of 10, 30 and 50 mg/kg body weight
inhibited the melanoma tumor development in nude
mice [88]. The trihydroxy benzoic acid (gallic acid at 0.3
and 1.0%) also inhibited the growth of osteocarcinomas
in xenograft mice models [89]. The data showed a
significant reduction in the tumor volume from
2392.99 mm3 in control group to 1896.34 mm3 and
1476.55 mm3 in the treated groups [89]. Another study
also demonstrated the anti-tumor potential of gallic acid.
Mice fed with 0.3 and 1% gallic acid for 20 weeks inhib-
ited the prostate cancer growth and progression to ad-
vanced stages [90]. Even the derivatives of phenolic
compounds also exhibited anti-cancer activity, which is
either similar to- or much better than parent underiva-
tized compound. A study reported that 4-methyl-3 nitro
benzoic acid derivative along with paclitaxel synergistic-
ally inhibited the metastasis of breast cancer in SCID
xenograft mice models [57]. Zhu, B. et al showed that
intragastric administration of cinnamic acid suppressed
the colon cancer in athymic mouse at a well-tolerated
dose 1.0 and 1.5 mmol/kg [91]. Irrespective of the mode
of administration, these phenolic acids are capable of
inhibiting the tumor growth in-vivo.
Mechanism of action
Effect on ROS generation
Reactive oxygen species such as hydroxyl radicals,
hydrogen peroxide and superoxide radicals are generated
on a regular basis during the mitochondrial respiration
[92]. Lower levels of ROS is involved in regulating sev-
eral signaling pathways that include cell survival, cell
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proliferation, metabolism, anti-oxidant and anti-
inflammatory responses, iron homeostasis etc. [93].
Moderate increase in the ROS levels is suppressed by
the anti-oxidant chemicals or proteins present in the
cells [94]. Therefore, in general, normal cells maintain a
fine balance in terms of ROS level. However, under cer-
tain conditions the levels of ROS exceeds the anti-
oxidant defense capacity leading to oxidative stress [95].
The free radicals produced in cells during oxidative
stress are highly reactive and capable of inducing tissue
damage by reacting with membrane lipids, nucleotides,
sulphydryl groups of proteins and by cross-linking/frag-
mentation of ribonucleoproteins [96]. As a result of
these ROS induced insults, the cells undergo transform-
ation and form a variety of tumors [97]. ROS generated
in the cancer cells are involved in activation of several
transcription factors including the NF-kβ, STAT3, acti-
vator protein-1 etc. which is essential in controlling cel-
lular proliferation, tumor survival, angiogenesis etc. [98].
In addition to DNA damage, ROS can induce alkali la-
bile sites, single strand breaks and damages to purines
and pyrimidines [98]. Although, tumor cells have higher
levels of ROS than the normal cells; elevated levels be-
yond the threshold for prolonged duration can induce
damage in cancer cells [52]. Therefore, promoting ROS
generation in cancer cells is a viable strategy to inhibit
tumor growth. For example, cinnamic acid derivative p-
coumaric acid triggered cancer cell death via increasing
the levels of ROS [52]. Likewise, a reduction in the mito-
chondrial membrane potential in the colon cancer cell
HCT-15 was reported when cells were exposed to caffeic
acid [99]. Thus elevating the ROS levels by treating with
phenolic compounds is a viable strategy to control can-
cer cells proliferation.
Effect on Oncogenic pathways
Mutations in the proto-oncogenes leads to formation of
oncogenes, which code for proteins that help cancer cells
proliferate and survive even in the conditions that are not
hostile [100]. For instance, oncogenic mutations in B-Raf
kinase have been reported in melanomas, colorectal, and
ovarian cancers [101]. Mutant V600EB-Raf is constitutively
active and doesn’t require the translocation and associ-
ation with Ras proteins for enzyme activity [102]. As a re-
sult, cells harboring this protein proliferate in an
uncontrolled fashion, which ultimately leads to the forma-
tion of malignant metastatic tumors [103]. Prior reports
evaluating the efficacy of targeting mutant oncogenic pro-
teins such as V600EB-Raf have shown decreased tumor
growth in preclinical animal models as well as in Phase-III
clinical trials [104]. Therefore identifying natural products
such as phenolic compounds that could effectively inhibit
B-Raf kinase signaling are the potential candidates for de-
veloping clinically viable drugs [105, 106].
Recently, caffeic acid has shown to inhibit the metasta-
sis of colon cancer by inhibiting the phosphorylation of
Extracellular signal Regulated Kinases (ERK) which is a
downstream target of Raf [107].
In addition, caffeic acid has been demonstrated to in-
hibit LPS-induced oxidative stress by retarding the ERK
signaling in endothelial cells [108]. Likewise, protocate-
chuic acid inhibited NF-kβ and MAPK signaling cas-
cades to down-regulate the proliferation of lung and
gastric carcinoma cells [44, 109]. Similarly, even the
ferulic acid and caffeic acid phenyl ester also down regu-
lated phosphorylated PI3K and AKT signaling cascades
to inhibit melanoma cells proliferation as well as to in-
duce apoptosis [88, 110]. Furthermore, in addition to
downregulating the phosphorylation of Akt kinase, Caf-
feic acid phenyl ester has suppressed the expression of
AKT isoforms in prostate cancer cells [111]. Few other
studies have also reported the therapeutic efficacy of cin-
namic acid derivatives such as ferulic acid, caffeic acid
and chlorogenic acids for treating cancers [112]. The
data revealed that these cinnamic acid derivatives down
modulate MAPK and AKT signaling pathways to inacti-
vate the NF-kβ, AP-1 and STAT3 in lung adenocarcin-
omas [112]. Thus phenolic acids are known to play a
crucial role in blocking the oncogenic pathways to in-
hibit cancer progression as shown in Fig. 5.
Effect on tumor suppressor pathways
Tumor suppressor genes protect normal cells by pre-
venting the oncogenic transformation into cancer cells
[113]. In general, tumor suppressors such as p53, PTEN,
Rb proteins help prevent the damage to DNA caused by
the high intensity radiation, toxic chemicals such as dyes
and infections especially by viruses [100]. In addition,
tumor suppressor proteins also help in the scavenging of
damaged cells through apoptosis [113]. Proof-of-
principle studies expressing the tumor suppressors, in
the cells where the expression of these genes is lost, due
to the chromosomal deletions or mutational inactivation;
have confirmed the anti-oncogenic role of these proteins
[76]. Therefore, compounds that can trigger the expres-
sion of tumor suppressor proteins are likely to inhibit
the development and transformation of cells into cancer-
ous ones [114]. In a recent study, caffeic acid phenyl es-
ters has been shown to arrest castration resistant
prostate cancer (CRPC) cells in the G0/G1 phase of the
cell cycle by upregulating p53, p21 and p27 proteins
[115]. Confirming this data, knocking down these tumor
suppressors using siRNA attenuated the efficacy of caf-
feic acid phenyl esters [115]. Similarly, an increase in the
expression of p53 was observed when cervical cancer
cells were exposed to caffeic acid [116]. Likewise, caffeic
acid phenyl ester and caffeic acid octyl ester could also
inhibit the growth of ME180 cervical cancer cells [117].
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Another phenolic compound that has been demon-
strated to upregulate tumor suppressors is ferulic acid.
Ferulic acid enhanced the levels of p53 and p21 mRNA
when transformed keratinocyte cell line HaCaT is ex-
posed to UVB radiation [118]. Even the benzoic acid de-
rivatives such as protocatechuic acid also induced the
levels of p21 and p27 in leiomyoma cells. However, no
major changes were reported, by this study, in the ex-
pression of p53 [119]. In summary, both cinnamic acid
and benzoic acid derivatives can induce cell cycle arrest
by inducing the expressions of the tumor suppressor
genes and thereby inhibit the tumor cell proliferation.
Effect on cytokine and cell differentiation pathways
Cytokines such as interferons, interleukins, tumor necro-
sis factor, lymphokines are low molecular weight proteins
involved in cell signaling, development and immune re-
sponses [120]. Uncontrolled release of cytokines during
oxidative stress or chronic inflammation induces malig-
nancy in normal cells [121]. Cancer cells responds to the
cytokines released by the host cells to induce cell growth,
inhibit apoptosis and induce metastasis [122]. For ex-
ample, cytokine IL-21 activates the STAT3 pathways by
upregulating the Myc-c expression [123]. Myc-c is a key
regulatory gene and is mutated in 70% cancers [114]. Mu-
tated Myc-c fails to control the differentiation of cells
[124]. Moreover, Myc-c gene is involved in cell cycle regu-
lation, differentiation, metabolism and cell growth. Hence,
molecules that promote anti-proliferative cytokines
expression are important anticancer agents. Protocate-
chuic acid is one such molecule known to lower the levels
of oncogenic IL-6 and IL-8 in a dose dependent fashion in
cancer cell lines representing the breast, prostate, cervix,
lung and liver [47]. Similar way, ferulic acid blocks the se-
cretion of IL-6 and TNF-α in HaCaT cells [118]. Other
phenolic compounds such as p-coumaric acid and caffeic
acid have downregulated the expression of Myc-c,
CCNB1, CCNA2 in CaCo2, HCT-116/SW480 cells
leading to inhibition of cellular differentiation and
proliferation [125].
Effect on matrix metalloproteinases
Matrix metalloproteinases are endopeptidases capable of
degrading the extracellular matrix [126]. Tumor cells ex-
press high levels of MMP, which degrade the extracellu-
lar matrix to promote tumor invasion and metastasis
[127]. Thus molecules that inhibit MMPs can success-
fully inhibit the tumor growth and proliferation. A re-
cent study demonstrated that protocatechuic acid
suppressed the matrix metalloproteinase (MMP-2 and
MMP-9) [109]. Similarly, ferulic acid inhibited the
MMP2 and MMP9 in HUVEC and melanoma cells
thereby inhibited the metastasis and angiogenesis of
these cells [88]. CAA and CAPE, two other cinnamic
acid derivatives, could selectively suppress the MMP-9
and MMP-2 activities to prevent hepatoma cells’ growth
and metastasis [86]. Hence, phenolic compounds with
MMP inhibitory properties could be considered for
Fig. 5 Key processes effected by plant phenolic acids Phenolic compounds are known to modulate the expression of key proteins such as BCL2,
BAX, AKT, STAT. While suppressing the oncogenic proteins, phenolic compounds induce the expression of tumor suppressors P53, P21 and P27.
As a result, phenolic compounds trigger apoptotic cell death while inhibiting the proliferation and inducing the cell cycle arrest [47]
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inhibiting the metastatic spread of tumor cells. However,
further studies are warranted to conclusively and experi-
mentally prove this data in preclinical animal models
and clinical testing in humans.
Adverse effects of phenolic compounds
Accumulating evidences from the literature suggests that
the phenolic compounds despite their enormous health
beneficial effects also possess adverse effects, which are pri-
marily due to: (a) poor permeability if they exist as free
acids; (b) the ability to transform normal cells in to cancer
cells thereby induce tumors in certain cases; (c) induce sys-
temic toxicity when administered in excess. Moreover, since
phenolic compounds are known to scavenge reactive oxy-
gen species, which are required for some of the key bio-
logical processes such as prevention of infections and
inflammatory reactions, administering phenolic compounds
to treat cancers might affect these processes and leads to
infections and unusual inflammatory reactions [128].
Toxicity
Although phenolic acids are well known for their anti-
oxidant activity, they also act as pro-oxidants in pres-
ence of redox active metals. This pro-oxidant effect
leads to deleterious effects on DNA, proteins and lipids
[128]. Further, at higher concentrations phenolic acids
can induce blisters and harm healthy cells. Thus the
dose and exposure time are critical while administering
phenolic acids [129]. Development of nanoformulations
is likely to help reduce these off target effects caused by
the phenolic acids.
Tumorogenicity
Despite the antitumor effects of phenolic acids, few reports
have shown tumor inducing properties [130]. For instance,
a study conducted by Miller et al in 2001 showed estro-
genic activity of phenolic acids, which lead to the develop-
ment of breast cancer [130]. In addition a study in animal
models has shown that 2% Caffeic acid administered
through diet could induce 57% forestomach squamous cell
carcinomas in female F344 rats and B6C3F1 mice [74]. Fur-
ther, since some phenolic acids at lower doses are known to
activate oncogenes, their administration is likely to induce
tumors growth [131]. For example, Nrf-2, a key redox regu-
lator, is activated by gallic acid and causes the induction of
chemoresistance [131]. Similarly, a study conducted by
Ashok et al 2015, also showed the ability of gallic acid to
upregulate Nrf-2 activity in mice models [132]. Few recent
studies have also demonstrated the ability of cinnamic acids
to upregulate Nrf2. For instance, a study has shown that
caffeic acid phenyl ester and ferulic acid activated the Nrf-2
expression in cancer cell lines [133, 134]. Despite these ad-
verse effects, the research and use of phenolic compounds
for treating cancers continues due to the predominance of
health beneficial effects compared to adverse events. In
addition, due to recent advancements in drug delivery and
treatment options, even the adverse effects of phenolic
compounds could also be easily managed, making the
phenolic compounds as the choice of treatment for
cancers.
Conclusions
Even though plant derived phenolic compounds have been
studied extensively for inhibiting tumor cell growth in
vitro and in vivo, many gaps still persist that require add-
itional studies. For example, cinnamic acid derivatives, caf-
feic acid and ferulic acid are known to down modulate
survival and proliferation signaling cascades such as PI3K-
Akt and MAPK pathways, respectively. However, it is not
fully known how these cinnamic acid derivatives are
retarding these signaling cascades. Are they binding to
Akt or Raf proteins? Or are they inhibiting the upstream
kinases/binding proteins? Therefore, additional studies are
required to address these concerns. Furthermore, experi-
mental data is required to address variations in treatment
response among individuals who are consuming phenolic
acid rich diet. Additional studies are also required to im-
prove the therapeutic efficacy and tumor cell selectivity of
phenolic compounds. Since benzoic and cinnamic acid de-
rivatives are effective only at higher doses (about 10–
20 mg/kg body weight) strategies to reduce the dose and
toxicity are urgently required. Hence, future studies
should focus on developing targeted nanoformulations
loaded with anti-tumor phenolic compounds. In conclu-
sion, the review summarized: (a) key structural features of
phenolic acids required for exhibiting anti-cancer activity;
(b) the recently published data highlighting the beneficial
effects of biotransformation of phenolic acids by gut
microbiota; (c) the mechanisms of action(s) of phenolic
acids leading to the inhibition of cancer cell proliferation
and migration; and (d) the preclinical data assessing the
pharmacological behavior including the safety and anti-
cancer activity of phenolic acids.
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